Seminars in arthritis and rheumatism
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Association between frailty and incident cancer in newly diagnosed patients with rheumatoid arthritis..
-.
2026
-
Characteristics and long-term outcomes of patients with rheumatoid arthritis and concurrent calcium pyrophosphate deposition disease..
-.
2025
-
Frailty carries an increased risk of death in rheumatoid arthritis..
-.
2025
-
Risk factors for incident atrial fibrillation in rheumatoid arthritis patients: A population based cohort study..
-.
2025
-
Weight loss, disease activity, and patient reported outcomes in patients with musculoskeletal and autoimmune diseases taking weight loss medications: a retrospective cohort study..
-.
2025
-
Sleep disorders in rheumatoid arthritis: Incidence, risk factors and association with dementia..
-.
2025
-
Incidence of aortic aneurysm, dissection, or rupture among patients with polymyalgia rheumatica and giant cell arteritis..
-.
2025
-
Prioritising domains of glucocorticoid therapy to measure in trials: Results from a modified delphi exercise from the OMERACT glucocorticoid impact working group..
-.
2024
-
The impact of cardiovascular and cerebrovascular disease on the risk of dementia in rheumatoid arthritis: A mediation analysis..
-.
2024
-
Evolving and evaluating the OMERACT fellows program: insights and implications from OMERACT 2023 fellows..
-.
2024
-
Multiple morbidities are associated with serious infections in patients with rheumatoid arthritis..
-.
2024
-
Obesity is an independent risk factor for cancer development following diagnosis of dermatomyositis..
-.
2023
-
Early referral of patients with suspected polymyalgia rheumatica - A systematic review..
-.
2023
-
Time Trends in Glucocorticoid Use in Rheumatoid Arthritis During the Biologics Era: 1999-2018..
-.
2023
-
Racial disparities in pregnancy outcomes among women with rheumatic diseases: A systematic literature review..
-.
2023
-
Is there a role for Pneumocystis jiroveci pneumonia prophylaxis in giant cell arteritis or polymyalgia rheumatica?.
-.
2022
-
Rituximab is associated with worse COVID-19 outcomes in patients with rheumatoid arthritis: A retrospective, nationally sampled cohort study from the U.S. National COVID Cohort Collaborative (N3C)..
-.
2022
-
Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group..
-.
2022
-
Association between work physical activity, dietary factors, and risk of rheumatoid arthritis..
-.
2022
-
Genetic, social, and environmental risk factors in rheumatoid arthritis-associated interstitial lung disease..
-.
2022
-
Incidence of dementia in patients with rheumatoid arthritis and association with disease modifying anti-rheumatic drugs - Analysis of a national claims database..
-.
2022
-
Adipocytokines and achievement of low disease activity in rheumatoid arthritis..
-.
2022
-
Reply to letters to the Editor re: Low cumulative disease activity is associated with higher bone mineral density in a majority Latinx and Asian US rheumatoid arthritis cohort..
-.
2022
-
Correspondence on "low cumulative disease activity is associated with higher bone mineral density in a majority Latinx and Asian US rheumatoid arthritis cohort" by Wysham et al..
-.
2022
-
To the editor: Response to Kao et al..
-.
2022
-
Low cumulative disease activity is associated with higher bone mineral density in a majority Latinx and Asian US rheumatoid arthritis cohort..
-.
2022
-
Association between work physical activity, dietary factors, and risk of rheumatoid arthritis.
57:152100.
2022
-
The point of no return? Functional disability transitions in patients with and without rheumatoid arthritis: A population-based cohort study..
52:151941.
2022
-
The point of no return? Functional disability transitions in patients with and without rheumatoid arthritis: A population-based cohort study..
-.
2021
-
Improving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective: The OMERACT glucocorticoid core domain set..
51:1139-1145.
2021
-
Trends in incidence of dementia among patients with rheumatoid arthritis: A population-based cohort study..
51:853-857.
2021
-
One Quarter of Medicare Hospitalizations in Patients with Systemic Lupus Erythematosus Readmitted within Thirty Days..
51:477-485.
2021
-
Predictors of Adverse outcomes in patients with systemic lupus erythematosus transitioning to adult care..
51:353-359.
2021
-
Association of cardiovascular disease and traditional cardiovascular risk factors with the incidence of dementia among patients with rheumatoid arthritis..
51:292-298.
2021
-
Trends in incidence of dementia among patients with rheumatoid arthritis: A population-based cohort study..
51:853-857.
2021
-
Incidence and progression of ankle osteoarthritis: The johnston county osteoarthritis project..
51:230-235.
2020
-
Racial and ethnic differences in medication use among beneficiaries of social security disability insurance with rheumatoid arthritis..
50:988-995.
2020
-
Acute respiratory viral adverse events during use of antirheumatic disease therapies: A scoping review..
50:1191-1201.
2020
-
Effect of statin use on the risk of rheumatoid arthritis: A systematic review and meta-analysis..
50:1348-1356.
2020
-
Definition and construct validation of clinically relevant cutoffs on the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire..
50:261-265.
2020
-
Effect of statin use on the risk of rheumatoid arthritis: A systematic review and meta-analysis..
50:1348-1356.
2020
-
Increased hospitalization rates following heart failure diagnosis in rheumatoid arthritis as compared to the general population..
50:25-29.
2020
-
Definition and construct validation of clinically relevant cutoffs on the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire..
50:261-265.
2019
-
Increased hospitalization rates following heart failure diagnosis in rheumatoid arthritis as compared to the general population..
50:25-29.
2019
-
Healthcare utilization and expenditures for United States Medicare beneficiaries with systemic vasculitis..
47:507-519.
2017
-
Colchicine--Update on mechanisms of action and therapeutic uses..
45:341-50.
2015
-
Lipid testing in patients with rheumatoid arthritis and key cardiovascular-related comorbidities: a medicare analysis..
42:9-16.
2012
-
Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: comparison with control subjects from the multi-ethnic study of atherosclerosis..
41:535-44.
2012
-
Therapeutic exercise for rheumatoid arthritis and osteoarthritis..
20:32-40.
1990
-
To the editor: Response to Kao et al.
2022
Identity
International Standard Serial Number (ISSN)